none
Conditions
Interventions
Test side:After receiving photon rejuvenation treatment, test samples were used on the side of the experiment.
Control side:After receiving photon rejuvenation treatment, the control side did not use the sample
Sponsors
Cosmetics Testing Center, Dermatology Hospital of Southern Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) Age18-45 years old, and is in good health condition; (2) dry or neutral skin; (3) the left and right red face is symmetrical; (4) Willing to accept photon skin rejuvenation treatment; (5) Those who can understand the experimental process, voluntarily participate in the experiment, and sign a written informed consent form.
Exclusion criteria
Exclusion criteria: (1) Women planning to conceive, conceive, breastfeed, and within six months postpartum; (2) Have a history of facial exposure to sunlight within six months; (3) Suffering from photosensitive skin diseases, such as vitiligo, photosensitive dermatitis, lupus erythematosus, etc; (4) Suffering from inflammatory skin diseases (rosacea, seborrheic dermatitis, hormone dependent dermatitis, contact dermatitis, special clinically untreated individuals with atopic dermatitis and swollen lupus erythematosus, etc; (5) Oral administration of retinoic acid within six months; (6) Oily skin, prone to acne on the face; (7) Facial melasma; (8) Individuals who have undergone photon rejuvenation, laser or other medical beauty treatments within six months; (9) Individuals with high physical sensitivity; (10) Individuals with severe systemic diseases, immunodeficiency, or autoimmune diseases; (11) Individuals who have used antihistamines in the past week or immunosuppressants in the past month; (12) Those who have used any anti-inflammatory drugs in the test site in the past two months; (13) Individuals who have participated in other clinical trials at the test site in the past three months; (14) Respiratory disease patients undergoing treatment; (15) The population undergoing dermatological treatment; (16) Patients with insulin dependent diabetes; (17) Non voluntary participants or those who are unable to complete the prescribed experimental content as required.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Facial image uptake and analysis;The measurement of transepidermal water loss;The measurement of stratum corneum;Self-assessment of subject; | — |
Secondary
| Measure | Time frame |
|---|---|
| The visual assessment of investigator; | — |
Countries
China
Contacts
Public ContactYe Li
Dermatology Hospital of Southern Medical University
Outcome results
None listed